Marie‐Pierre Galais

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

Frédéric FIORE, Frédéric Blanchard, F. Charbonnier et al. · British Journal of Cancer · 2007 · 734 citations · Full text

Medicine, Oncology, Pharmacology +17

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

Zhihao Lü, Junye Wang, Yongqian Shu et al. · BMJ · 2022 · 480 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

Thierry Conroy, Marie‐Pierre Galais, Jean‐Luc Raoul et al. · The Lancet Oncology · 2014 · 446 citations

Medicine, Oncology, Radiation Oncology +15

Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma

Jean‐Baptiste Bachet, Fabien Gay, Raphaël Maréchal et al. · Pancreas · 2015 · 80 citations

Medicine, Oncology, Pharmacology +11

Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis

Delphine Mariotte, Benoît Dupont, Radj Gervais et al. · mAbs · 2011 · 60 citations · Full text

Life Sciences, Immunology, Oncology +17